University of Richmond Basketball Player Diagnosed with Hodgkin’s Lymphoma
University of Richmond men's basketball player Jack McCaffery has been diagnosed with Hodgkin's lymphoma and is undergoing treatment at the University of Pennsylvania's Hospital.
Roanoke Lynchburg, VA, November 8, 2026 —
University of Richmond men’s basketball player Jack McCaffery has been diagnosed with Hodgkin’s lymphoma. The diagnosis was recently confirmed, and McCaffery has begun undergoing treatment for the condition.
McCaffery is receiving care at the University of Pennsylvania’s Hospital. Further details regarding the specific treatment plan or prognosis were not provided in the initial report. The duration of his treatment and its potential impact on his basketball career are also not specified at this time.
Hodgkin’s lymphoma is a type of cancer that affects the lymphatic system, a network of vessels and nodes that is part of the immune and circulatory systems. According to general medical information, it is characterized by the presence of specific abnormal cells in the lymph nodes, known as Reed-Sternberg cells. Symptoms can include swelling of lymph nodes, fever, weight loss, and fatigue. The disease is often treated with chemotherapy, radiation therapy, or immunotherapy, and treatment plans are typically tailored to the stage and type of lymphoma.
The University of Richmond has not released further statements regarding McCaffery’s health or the team’s plans in his absence. The specific circumstances leading to the diagnosis or the timeline of when it was made were not disclosed. The athlete’s family has not publicly commented beyond the information provided about his treatment location. The exact nature of his involvement in team activities moving forward remains unknown.
Story summarized from the original created by 12 On Your Side Digital Team on www.wdbj7.com, see more information here.
Media gallery
